Polymyxin B hemoperfusion: a mechanistic perspective
Open Access
- 1 January 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 18 (3), 309
- https://doi.org/10.1186/cc13912
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Blood Purification and Mortality in SepsisCritical Care Medicine, 2013
- Combining intermediate levels of the Endotoxin Activity Assay (EAA) with other biomarkers in the assessment of patients with sepsis: results of an observational studyCritical Care, 2012
- Endotoxemia related to cardiopulmonary bypass is associated with increased risk of infection after cardiac surgery: a prospective observational studyCritical Care, 2011
- Translocation of bacterial NOD2 agonist and its link with inflammationCritical Care, 2009
- Polymyxin-B hemoperfusion inactivates circulating proapoptotic factorsIntensive Care Medicine, 2008
- DAILY VARIATION IN ENDOTOXIN LEVELS IS ASSOCIATED WITH INCREASED ORGAN FAILURE IN CRITICALLY ILL PATIENTSShock, 2007
- Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic reviewCritical Care, 2007
- A PILOT-CONTROLLED STUDY OF A POLYMYXIN B-IMMOBILIZED HEMOPERFUSION CARTRIDGE IN PATIENTS WITH SEVERE SEPSIS SECONDARY TO INTRA-ABDOMINAL INFECTIONShock, 2005
- Direct hemoperfusion with polymyxin B-immobilized fiber improves shock and hypoxemia during endotoxemia in anesthetized sheepInnate Immunity, 2002
- Direct hemoperfusion with polymyxin B-immobilized fiber improves shock and hypoxemia during endotoxemia in anesthetized sheepInnate Immunity, 2002